Heteromeric TRPV4/TRPC1 channels mediate calcium-sensing receptor-induced nitric oxide production and vasorelaxation in rabbit mesenteric arteries. by Greenberg, HZE et al.
Contents lists available at ScienceDirect
Vascular Pharmacology
journal homepage: www.elsevier.com/locate/vph
Heteromeric TRPV4/TRPC1 channels mediate calcium-sensing receptor-
induced nitric oxide production and vasorelaxation in rabbit mesenteric
arteries
Harry Z.E. Greenberg⁎, Simonette R.E. Carlton-Carew, Dhanak M. Khan, Alexander K. Zargaran,
Kazi S. Jahan, W.-S. Vanessa Ho, Anthony P. Albert
Vascular Biology Research Centre, Molecular & Clinical Sciences Research Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK
A B S T R A C T
Stimulation of calcium-sensing receptors (CaSR) by increasing the external calcium concentration (Ca2+]o)
induces endothelium-dependent vasorelaxation through nitric oxide (NO) production and activation of inter-
mediate Ca2+-activated K+ currents (IKCa) channels in rabbit mesenteric arteries. The present study investigates
the potential role of heteromeric TRPV4-TRPC1 channels in mediating these CaSR-induced vascular responses.
Immunocytochemical and proximity ligation assays showed that TRPV4 and TRPC1 proteins were expressed and
co-localised at the plasma membrane of freshly isolated endothelial cells (ECs). In wire myography studies,
increasing [Ca2+]o between 1 and 6 mM induced concentration-dependent relaxations of methoxamine (MO)-
induced pre-contracted tone, which were inhibited by the TRPV4 antagonists RN1734 and HC067047, and the
externally-acting TRPC1 blocking antibody T1E3. In addition, CaSR-evoked NO production in ECs measured
using the ﬂuorescent NO indicator DAF-FM was reduced by RN1734 and T1E3. In contrast, [Ca2+]o-evoked
perforated-patch IKCa currents in ECs were unaﬀected by RN1734 and T1E3. The TRPV4 agonist GSK1016790A
(GSK) induced endothelium-dependent relaxation of MO-evoked pre-contracted tone and increased NO pro-
duction, which were inhibited by the NO synthase inhibitor L-NAME, RN1734 and T1E3. GSK activated 6pS
cation channel activity in cell-attached patches from ECs which was blocked by RN1734 and T1E3. These
ﬁndings indicate that heteromeric TRPV4-TRPC1 channels mediate CaSR-induced vasorelaxation through NO
production but not IKCa channel activation in rabbit mesenteric arteries. This further implicates CaSR-induced
pathways and heteromeric TRPV4-TRPC1 channels in regulating vascular tone.
1. Introduction
Stimulation of plasmalemmal calcium-sensing receptors (CaSR) by
an increase in the extracellular Ca2+ concentration ([Ca2+]o) is in-
volved in maintaining plasma Ca2+ homeostasis through the regulation
of parathyroid hormone synthesis and secretion from the parathyroid
gland, intestinal Ca2+ absorption, and renal Ca2+ excretion [6,7,27]. It
is also increasingly apparent that CaSR are expressed in tissues not
involved in plasma Ca2+ homeostasis, including the cardiovascular
system [42,49,60].
In the vasculature, functional expression of CaSR in perivascular
nerves, endothelial cells (ECs), and vascular smooth muscle cells
(VSMCs) is proposed to regulate vascular tone, and may be potential
targets for controlling blood pressure [2,9,24,28,30,32,55,58,59]. In
the presence of closely regulated plasma Ca2+ levels, stimulation of
CaSR in the vasculature is considered physiologically possible as loca-
lised [Ca2+]o is likely to rise suﬃciently at the surface of cells due to
active Ca2+ transport mechanisms such as the Ca2+-ATPase and the
Na+-Ca2+ exchanger, as well as opening and closing of voltage-de-
pendent Ca2+ channels [16,27,28,40,44]. There is currently little
consensus on the function of CaSR in the vasculature, with ﬁndings
suggesting that stimulation of CaSR induce both vasoconstriction and
vasorelaxation through diverse cellular mechanisms
[9,16,24,28,30,57,58,60].
We recently reported that stimulation of CaSR by increasing
[Ca2+]o induces an endothelium-dependent vasorelaxation in rabbit
mesenteric arteries, which required stimulation of the nitric oxide
(NO)-guanylate cyclase (GC)-protein kinase G (PKG) pathway coupled
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to activation of large conductance Ca2+-activated K+ (BKCa) channels
in VSMCs, and activation of intermediate conductance Ca2+-activated
K+ (IKCa) channels inducing endothelium-derived hyperpolarisations
[24]. It is unclear how stimulation of CaSR induces these mechanisms,
but as endothelium NO synthase (eNOS) and IKCa channel activation
both require a rise in intracellular Ca2+ concentration ([Ca2+]i)
[10,11], it seems highly plausible that Ca2+ inﬂux mechanisms are
involved. This question forms the focus of the present study.
The transient receptor potential (TRP) superfamily of Ca2+-
permeable cation channels form ubiquitously expressed Ca2+ inﬂux
pathways, and several TRP channels are functionally expressed in ECs
[19–22,29,37,43,45,53,54,63]. In particular, there is increasing evi-
dence indicating that TRPV4 channels have a major role in regulating
vascular tone, including mediating ﬂow- and agonist-induced vasodi-
latations via stimulation of NO production and IKCa channel activation
in ECs [3,4,8,18,26,37,38,51,52]. It has also been proposed that
TRPV4-mediated vascular responses are mediated by heteromeric
TRPV4-TRPC1 channel structures expressed in ECs [17,33–36,64]).
Therefore, the present work investigates the role of TRPV4, TRPC1, and
possible heteromeric TRPV4-TRPC1 channels in CaSR-induced vasor-
elaxation in rabbit mesenteric arteries. From our ﬁndings using wire
myography, ﬂuorescent microscopy, and electrophysiological techni-
ques, we propose that heteromeric TRPV4-TRPC1 channels mediate
CaSR-induced vasorelaxation and NO production but are not involved
in CaSR-induced IKCa channel activation.
2. Methods
2.1. Animals
In this study, male New Zealand white rabbits aged 12–16 weeks
and weighing 2.5–3 kg were used to examine vascular CaSR mechan-
isms previously investigated [24]. Rabbits were sourced from Highgate
Farm, Louth, United Kingdom. The animals were housed in the Biolo-
gical Research Facility (BRF) at St George's University of London ac-
cording to the requirements of the Code of Practice for animal hus-
bandry contained within the Animals Scientiﬁc Procedures Act 1986 as
amended in 2012. Rabbits were socially housed in pairs and provided
with appropriately-sized multi-compartment cages. Room environ-
mental conditions were controlled by an automated building manage-
ment system that maintained a light:dark cycle of 12:12 h, a room
ambient temperature within a range of 18–22 °C, and a relative hu-
midity of 50 ± 10%. Rabbits received ad lib fresh water, a daily al-
lowance of laboratory maintenance rabbit diet, and irradiated hay as an
additional source of dietary ﬁbre (Specialist Dietary Services (SDS) UK).
Rabbits were killed within 2–4 weeks of arrival by intravenous injection
of sodium pentobarbitone (120 mg kg−1) into the peripheral ear vein in
accordance with Schedule I of the UK Animals Scientiﬁc Procedures
Act, 1986 and St George's University of London Animal Welfare and
Ethical Review Committee.
2.2. Cell and vessel segment preparation
Second-order branches of rabbit superior mesenteric artery were
dissected and cleaned of adherent tissue in physiological salt solution
(PSS) containing (mM): NaCl 126, KCl 6, Glucose 10, HEPES 11, MgCl2
1.2, and CaCl2 1.5, with pH adjusted to 7.2 with 10 M NaOH. Following
dissection, vessels were either cut into 2 mm segments for wire myo-
graphy studies or were enzymatically dispersed to obtain freshly iso-
lated ECs. To isolate single ECs, vessels were washed in PSS containing
50 μM [Ca2+]o for 5 min at 37 °C and placed in collagenase solution
(1 mg ml−1) for 14 min at 37 °C. The vessels were then triturated in
fresh PSS and the cell-containing solution was collected and centrifuged
for 1 min at 1000 rpm. The supernatant was removed and the cells re-
suspended in fresh PSS containing 0.75 mM [Ca2+]o, plated onto cov-
erslips, and left at 4 °C for 1 h before use.
2.3. Immunocytochemistry
Freshly dispersed ECs were ﬁxed onto borosilicate coverslips with
4% paraformaldehyde (Sigma-Aldrich, Gillingham, UK) for 10 min,
washed 3 times with phosphate-buﬀered saline (PBS), and permeabi-
lised with PBS containing 0.1% Triton X-100 for 20 min at room tem-
perature. Cells were then washed 3 times with PBS and incubated with
PBS containing 1% bovine serum albumin (BSA) for 1 h at room tem-
perature. The cells were then incubated overnight at 4 °C with goat-
TRPV4 antibodies (1:200, Santa Cruz, Sc47-525) and T1E3, a rabbit
anti-TRPC1 antibody generated by GenScript (Piscataway, NJ, USA)
using a peptide sequence from a characterised putative extracellular
pore region of the TRPC1 subunit [61]. The cells were then washed 3
times with PBS and incubated with secondary antibodies conjugated to
ﬂuorescent probes, Alexa Fluor 546-conjugated donkey anti-goat anti-
body (1:500) or Alexa Fluor 488-conjugated donkey anti-rabbit anti-
bodies (1:500; Thermo Fisher Scientiﬁc, Walham, MA, USA). Unbound
secondary antibodies were removed by washing with PBS, and nuclei
were labelled with 4′,6-diamidino-2-phenylindole (DAPI) mounting
medium (Sigma-Aldrich). In control experiments, cells were incubated
without primary or secondary antibodies. Cells were imaged using a
Zeiss LSM 510 laser scanning confocal microscope (Carl Zeiss, Jena,
Germany). Excitation was produced by 546 nm or 488 nm lasers and
delivered to the specimen via a Zeiss Apochromat ×63 oil-immersion
objective. Emitted ﬂuorescence was captured using LSM 510 software
(release 3.2; Carl Zeiss). Two-dimensional images cut horizontally
through the middle of the cells were captured and raw confocal imaging
data processed using Zeiss LSM 510 software. Final images were pro-
duced using PowerPoint (Microsoft XP; Microsoft, Richmond, WA,
USA).
2.4. Proximity ligation assay
Freshly isolated ECs were studied using the Duolink in situ proxi-
mity ligation assay (PLA) detection kit 563 (Olink, Uppsala, Sweden)
[50]. Cells were plated onto coverslips, ﬁxed with PBS containing 4%
paraformaldehyde for 15 min, and permeabilized in PBS containing
0.1% Triton X-100 for 15 min. Cells were blocked for 1 h at 37 °C in
blocking solution, and incubated overnight at 4 °C with anti-TRPV4 and
T1E3 antibodies (both at dilution 1:200) in antibody diluent solution.
Cells were labelled with combinations of either anti-goat PLUS/anti-
rabbit MINUS 1 h at 37 °C. Hybridized oligonucleotides were ligated for
30 min at 37 °C prior to ampliﬁcation for 100 min at 37 °C. Red ﬂuor-
escence-labelled oligonucleotides were then hybridized to rolling circle
ampliﬁcation products, and visualized using a Confocal LSM 510 (Carl
Zeiss).
2.5. Isometric tension recordings
Eﬀects of stimulating CaSR and TRPV4-containing channels on
vascular tone were investigated using wire myography. Vessel segments
of 2 mm in length were mounted in a wire myograph (Model 610 M;
Danish Myo Technology, Aarhus, Denmark) and equilibrated for 30 min
at 37 °C in 5 ml of gassed (95% O2/5% CO2) Krebs–Henseleit solution of
the following composition (mM): NaCl 118, KCl 4.7, MgSO4 1.2,
KH2PO4 1.2, NaHCO3 25, CaCl2 2, D-glucose 10, pH 7.2. Vessels were
then normalised to 90% of the internal circumference predicted to
occur under a transmural pressure of 100 mmHg [39]. After normal-
isation, vessels were left for 10 min and were then challenged with
60 mM KCl for 5 min. Endothelium integrity was assessed by stably pre-
contracting vessels with 10 μM methoxamine followed by the addition
of 10 μM carbachol (CCh). Vessels in which CCh-induced relaxations
were> 90% of pre-contracted tone were designated as having a func-
tional endothelium. When required, endothelium was removed by
rubbing the intima layer with a human hair and CCh-induced relaxa-
tions of< 10% of pre-contracted tone indicated successful removal.
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Vessel segments were incubated for 30 min in fresh Krebs solution
containing 1 mM CaCl2 and then pre-contracted with 10 μM methox-
amine as required. This was followed by cumulative additions of CaCl2,
increasing [Ca2+]o between 1 and 6 mM, or 10 nM GSK1016790A in
the presence of inhibitors tested or their respective vehicles. All in-
hibitors were added to the vessel segments 30 min before the con-
struction of concentration-response curves to [Ca2+]o or
GSK1016790A. For each experiment, vehicle controls were performed
using vessel segments from the same animal.
2.6. NO imaging
ECs were placed in a sterilised 96-well plate and left for 1 h at 4 °C.
Cells were loaded with the NO ﬂuorescent dye DAF-FM diacetate
(1 μM), incubated at 4 °C for 20 min and then washed with PSS con-
taining 1 mM [Ca2+]o. The cells were then left for another 30 min at
4 °C to allow complete de-esteriﬁcation of intracellular diacetate.
Inhibitors tested or their respective vehicles were also added at this
point. Changes in ﬂuorescence following 5 min of CaSR stimulation
with 6 mM [Ca2+]o, 10 nM GSK1016790A, or 10 μM capsaicin were
captured using a Zeiss Axiovert 200 M Inverted microscope and pro-
cessed and analysed using AxioVision SE64 Software (Rel. 4.9.1; Carl
Zeiss).
2.7. Electrophysiology
Whole-cell and perforated-patch clamp conﬁgurations were used to
record K+ conductances and single cation channel currents were
measured using cell-attached patches. Recordings were made with an
Axopatch 200B ampliﬁer (Axon Instruments, Union City, CA, USA) at
room temperature (20–23 °C). Whole-cell and perforated-patch currents
were ﬁltered at 1 kHz (−3 dB, low-pass 8-pole Bessel ﬁlter, Frequency
Devices model LP02; Scensys, Aylesbury, UK) and sampled at 5 kHz
(Digidata 1322A and pCLAMP 9.0 software; Molecular Devices,
Sunnydale, CA, USA), whereas single cation channel currents were ﬁl-
tered at 100 Hz and sampled at 1 kHz.
Whole-cell K+ currents were evoked by dialysing cells with a pip-
ette solution containing 3 μM free Ca2+ and perforated-patch K+ cur-
rents were induced by bath applying 6 mM [Ca2+]o. Current/voltage
relationships (I/V) were obtained by applying a 200 ms voltage ramp
from −100 mV to +100 mV every 30 s from a holding potential of
−60 mV. The external bathing solution for both whole-cell and per-
forated-patch recordings contained (mM): NaCl 134, KCl 6, Glucose 10,
HEPES 10, MgCl2 1, CaCl2 1 (adjusted to pH 7.4 with 10 M NaOH). For
whole-cell recordings, the pipette solution contained (mM): KCl 134,
HEDTA 5, HEPES 10, MgCl2 5.53 (1 mM free Mg2+) and CaCl2 0.207
(3 μM free Ca2+) (pH 7.2). The amounts of MgCl2 and CaCl2 added
were determined using EqCal software (Biosoft, Cambridge, UK). For
perforated-patch recordings the pipette solution contained (mM): K-
aspartate 110, KCl 30, NaCl 10, HEPES 10, MgCl2 1, pH 7.2 with 10 M
NaOH, and amphotericin (200 μg ml−1). The external bathing solution
for cell-attached patch recordings contained (mM): 126 KCl, 1 CaCl2, 10
HEPES, and 11 glucose, adjusted to pH 7.2 with 10 M KOH. The patch
pipette solution contained (mM): 126 NaCl, 1 CaCl2, 10 HEPES, and 11
glucose adjusted to pH 7.2 with 10 M NaOH. 100 μM DIDS, 100 μM
niﬂumic acid, 10 mM TEA, 100 nM Apamin (Apa), and 100 nM
Charybdotoxin (CbTX) were also included in the patch pipette solution
to block Ca2+ and swell-activated Cl− conductances, voltage-gated K+
channels, and SKCa, IKCa, and BKCa channels respectively. This enabled
cation conductances to be recorded in isolation. Single cation channel
currents were activated by including 10 nM GSK1016790A in the patch
pipette solution.
2.8. Data and statistical analysis
All data presented are mean ± SEM and for all experiments,
P < 0.05 was considered a signiﬁcant diﬀerence between groups. For
whole cell and perforated patch clamp recordings, data were analysed
using 2-way ANOVA, comparing the eﬀect of increasing voltage on
membrane current in treated vs. control cells. Figures and analyses
were made using MicroCal Origin 6.0 software (MicroCal Software,
Northampton, MA, USA). For wire myography experiments, all relaxant
responses are expressed as percentage relaxation of tension induced by
10 μM methoxamine. Responses to increasing [Ca2+]o in treated vs.
control vessels were analysed by 2-way ANOVA followed by Bonferroni
post hoc tests. Bonferroni comparisons are shown above the graph data
points whereby: *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001 vs. control. For GSK1016790A-induced responses,
data were compared using One-way ANOVA. Statistical analyses, in-
cluding calculation of EC50 and Emax values, and all graphs were made
using Graphpad Prism 6 software (GraphPad Software, Inc., San Diego,
CA, USA). For NO imaging experiments, changes in ﬂuorescence were
quantiﬁed by selecting a cell as a region of interest (ROI) and com-
paring ﬂuorescence levels within the ROI before and after the experi-
mental protocols and analysed using One-way ANOVA. Figures and
analysis were made using Graphpad Prism 6 (GraphPad Software, Inc.,
San Diego, CA, USA).
2.9. Materials
All drugs were purchased from Sigma-Aldrich (Sigma Chemical Co.,
Poole, UK) or Tocris (Tocris Biosciences, Bristol, UK). Drugs were dis-
solved in distilled water or dimethyl sulfoxide (DMSO).
3. Results
3.1. TRPV4 and TRPC1 channel proteins are colocalised in rabbit
mesenteric artery ECs
In our initial experiments, we examined the expression of TRPV4,
TRPC1, and potential co-localisation between these two channel pro-
teins in freshly isolated rabbit mesenteric artery ECs. Fig. 1A shows that
TRPV4 and TRPC1 proteins were expressed in ECs using im-
munocytochemistry, with staining and co-localisation present at the
plasma membrane. Fig. 1B provides further evidence using proximity
ligation assay that TRPV4 and TRPC1 co-localisation signals were
present in ECs.
3.2. CaSR-induced vasorelaxation and NO production are reduced by
TRPV4 and TRPC1 channel inhibitors in rabbit mesenteric artery
In this series of experiments, we investigated the eﬀect of the TRPV4
channel blockers RN1734 and HC067047 [3,51,56], and the externally-
acting TRPC1 antibody T1E3, which is known to act as a TRPC1
channel blocking agent [46,61] on CaSR-induced vasorelaxation and
NO production.
Fig. 2 shows that increasing [Ca2+]o between 1 and 6 mM produced
concentration-dependent relaxation of pre-contracted tone induced by
10 μM methoxamine, previously shown to be mediated by stimulation
of CaSR [24]. [Ca2+]o -evoked relaxation was reduced following pre-
treatment of vessel segments with 30 μM RN1734, 1 μM HC067047,
and 1 μg ml−1 T1E3 (Table 1). To show selectivity of the inhibitory
response to T1E3, pre-incubation of T1E3 with its antigenic peptide
(AgP) prevented application of this antibody attenuating [Ca2+]o-in-
duced relaxation (Table 1).
Fig. 3 reveals that increasing [Ca2+]o from 1 mM to 6 mM po-
tentiated baseline DAF-FM ﬂuorescence by over 30%, which was in-
hibited by pre-treatment with the calcilytic 3 μM Calhex-231, the NO
synthase inhibitor 300 μM L-NAME, and RN1734 and T1E3. It was
apparent that RN1734 had a greater inhibitory eﬀect on [Ca2+]o-in-
duced vasorelaxation and increases in DAF-FM ﬂuorescence than T1E3.
In control experiments, Fig. 4A shows that pre-treatment with
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RN1734, HC067047, and T1E3 had no eﬀect on relaxations of pre-
contracted tone induced by the NO donor 10 μM SNP. In addition,
Fig. 4B demonstrates that increases in DAF-FM ﬂuorescence evoked by
the selective TRPV1 agonist 10 μM capsaicin were unaﬀected by
RN1734 and T1E3. These results indicate that RN1734, HC067047, and
T1E3 do not alter the ability of vessel segments to relax, and that
RN1734 and T1E3 do not produce non-speciﬁc reductions in NO pro-
duction.
3.3. CaSR-induced IKCa currents are unaﬀected by TRPV4 and TRPC1
channel inhibitors in rabbit mesenteric artery ECs
Fig. 5A shows that increasing [Ca2+]o from 1 mM to 6 mM evoked a
mean macroscopic K+ current in freshly isolated ECs using the perfo-
rated-patch conﬁguration, which had inward rectiﬁcation at positive
membrane potentials, reversed near to equilibrium potential for K+
ions (EK is −80 mV), and was abolished by the IKCa channel blocker,
100 nM charybdotoxin (CbTX). These properties are consistent with
previous studies demonstrating that stimulation of CaSR activates IKCa
currents [24,58]. Interestingly, [Ca2+]o-induced IKCa currents were not
inhibited by RN1734 and T1E3, but were prevented by the cation
channel blocker, and pan-selective TRP channel inhibitor, 100 μM
Gd3+[5]. Fig. 5B shows that inclusion of 3 μM free Ca2+ in the patch
pipette solution evoked a mean whole-cell K+ current which was in-
hibited by co-application of both CbTX and the small-conductance
Ca2+-activated K+ channel (SKCa) blocker 100 nM Apamin and there-
fore composed of IKCa and SKCa channels [24], but was unaﬀected by
Gd3+. This indicates that Gd3+ is not directly blocking IKCa or SKCa
channels but is likely to be blocking a Ca2+ inﬂux pathway.
These results provide pharmacological evidence that channels
composed of TRPV4 and TRPC1 are involved in CaSR-induced
vasorelaxation and NO production but are unlikely to be required for
CaSR-induced IKCa channel activation.
3.4. Vasorelaxations and NO production stimulated by the TRPV4 agonist
GSK are reduced by both TRPV4 and TRPC1 inhibitors
As the present study suggests that heteromeric TRPV4-TRPC1
channels may mediate CaSR-induced vasorelaxation and NO produc-
tion, we hypothesised that the selective TRPV4 agonist GSK101970A
(herein termed GSK) would induce vasorelaxation and NO production
which are inhibited by TRPC1 blockade. Fig. 6A, B & C illustrate that
GSK produced a concentration-dependent relaxation of pre-contracted
tone of rabbit mesenteric artery segments, which were reduced by re-
moval of the endothelium, and by pre-treatment with L-NAME,
RN1734, and T1E3. Moreover, Fig. 6D & E also show that GSK induced
an increase in baseline DAF-FM ﬂuorescence by about 40% which was
attenuated by L-NAME, RN1734, and T1E3. Together, these results
indicate that TRPC1 contributes to GSK-induced vasorelaxation and NO
production.
3.5. GSK activates cation channel activity in ECs which is reduced by both
TRPV4 and TRPC1 inhibitors
In our ﬁnal experiments, we investigated single TRPV4-containing
channel activity in ECs activated by GSK. Fig. 7A & B show that inclu-
sion of 10 nM GSK in the patch pipette solution evoked single cation
channel activity in cell-attached patches from ECs, which had similar
current amplitudes of about −0.5pA at −80 mV that corresponded to
unitary conductances of about 6pS. Fig. 7A shows that cation channel
activity was not recorded when GSK was absent from the patch pipette
solution. Fig. 7C &D reveal that when included on its own, GSK-evoked
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Fig. 1. Expression and co-localisation of heteromeric TRPV4-TRPC1 channels in freshly isolated mesenteric artery ECs.
A, Representative immunocytochemical images of TRPV4 (red) and TRPC1 (green) proteins in rabbit mesenteric artery ECs, showing expression and co-localisation (yellow) at the plasma
membrane. Representative images showing that the absence of primary anti-TRPV4 and anti-TRPC1 antibodies, or their corresponding secondary antibodies failed to produce any
immunocytochemical staining. B, Representative images from proximity ligation assays illustrating TRPV4 and TRPC1 co-localisation staining (red) in rabbit ECs. In the absence of
primary anti-TRPV4 and anti-TRPC1 antibodies failed to produce any PLA staining.
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6pS cation channel activity was maintained throughout the recording
(> 5 min) whereas when either RN1734 or T1E3 were co-applied in the
patch pipette solution GSK-evoked cation channel activity was greatly
reduced by over 80% and 70% respectively after 5 min.
These results suggest that native TRPV4-containing channels acti-
vated by GSK in rabbit mesenteric artery ECs are likely to be composed
of a single channel structure with a unitary conductance of 6pS, which
is composed of TRPV4 and TRPC1 channel proteins.
4. Discussion
The present study proposes that heteromeric TRPV4-TRPC1 chan-
nels mediate CaSR-induced vasorelaxation through NO production but
not activation of IKCa channels in rabbit mesenteric artery ECs.
Interestingly, our ﬁndings suggest that TRPV4-TRPC1 channels with a
unitary conductance of 6pS may be the predominant native TRPV4-
containing channels in these ECs.
4.1. Heteromeric TRPV4-TRPC1 channels mediated CaSR-induced
vasorelaxation via NO production
The present study together with our recent ﬁndings indicate that
stimulation of CaSR by increasing [Ca2+]o induces an endothelium-
dependent relaxation of rabbit mesenteric arteries, with a signiﬁcant
contribution involving NO production [24,25].
Our current results reveal that TRPV4 and TRPC1 proteins are co-
localised in ECs, and that CaSR-induced vasorelaxation and NO gen-
eration are both inhibited by the TRPV4 inhibitors RN1734 and
HC067047, and the TRPC1 blocking antibody T1E3. Our conclusion is
further supported by GSK-induced vasorelaxation and NO production
also being inhibited by RN1734 and T1E3. These results are in agree-
ment with earlier studies which proposed that a heteromeric TRPV4-
TRPC1 channel is expressed in ECs, which is also thought to be com-
posed of TRPP2 subunits [17,33–36,64]. This makes this channel rather
unique in that it is composed of subunits from three diﬀerent sub-
families of the TRP channel superfamily.
In combination with our earlier ﬁndings, we propose that stimula-
tion of CaSR activates TRPV4-TRPC1-mediated Ca2+ inﬂux, which
leads to Ca2+-CaM-eNOS inducing the classical NO-GC-PKG pathway
and vasorelaxation. Thus taken together, these data make an important
contribution to our current understanding of how CaSR might regulate
vascular tone. Physiologically, it is thought that plasmalemmal Ca2+
pumps and exchangers contribute to signiﬁcant increases in [Ca2+]o
within the local vascular microenvironment, producing extracellular
Ca2+ clouds within the vascular interstitium. These Ca2+ clouds then
stimulate vascular CaSR to regulate the contractile state of VSMCs as
well as the character of endothelial-dependent regulation of vascular
tone ([14,16,44,60,65]). Though the current study uses a range of
[Ca2+]o to stimulate CaSR (1–6 mM), future work will be required to
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Fig. 2. Eﬀect of TRPV4 and TRPC1 blockers on [Ca2+]o-induced relaxation in rabbit mesenteric arteries.
A Representative traces and B, mean data showing the inhibitory eﬀect of the TRPV4 antagonists RN1734 and HC067047, and the TRPC1 blocker T1E3 on [Ca2+]o-induced relaxations of
pre-contracted tone. Pre-incubation of T1E3 with AgP prevented the inhibitory action of TIE3. n = 5 animals, 3 vessel segments per animal.
Table 1
Eﬀect of various inhibitors tested on [Ca2+]o-induced vasorelaxation.
Rabbit EC50 (mM) Emax (%) N
Control 2.2 ± 0.06 92.7 ± 4.2 8
+ RN1734 (30 μM) 4.3 ± 0.1* 24 ± 7.5* 5
+ HC067047 (1 μM) 2.1 ± 0.04 39.7 ± 8.9* 5
+ T1E3 (1 μg ml−1) 2.8 ± 0.12* 34.7 ± 6.7* 5
+ T1E3 + AgP 2.2 ± 0.07 92.6 ± 1.9 5
Data shown are mean values ± SEM. Data are compared by unpaired Student's t-test
with *P < 0.05 vs. respective control group considered signiﬁcant. N = number of an-
imals used, with at least 3 vessel segments used per animal.
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establish the precise physiological changes in [Ca2+]o occurring within
the vascular microenvironment in order to fully understand how CaSR
might regulate vascular tone.
Previous studies have shown that heteromeric TRPV4-TRPC1
channels behave as store-operated channels in ECs, and that TRPC1
confers the ability of TRP channels to be activated by store depletion
via STIM1-mediated mechanisms in diﬀerent cell types
[1,34,35,41,46–48,54,62]. Given that CaSR predominantly couple to
Gαq-PLC-IP3 signaling when stimulated by [Ca2+]o[13], we propose
that CaSR-induced heteromeric TRPV4-TRPC1 channel activation
might occur downstream of Ca2+ store depletion and the translocation
of STIM1 to the channel, though it will be important to clarify the
precise mechanism in future work.
TRPC6 channels have been previously linked to CaSR-induced
contraction, proliferation and migration of VSMCs in pulmonary ar-
terial hypertension [55], and to CaSR-mediated rises in [Ca2+]i in
human aortic VSMCs [12]. However, the present ﬁndings provide the
ﬁrst evidence that TRP channels mediate CaSR-induced responses in
ECs, representing an important advance in our understanding of how
stimulation of CaSR regulates vascular tone. Our data also contributes
to the signiﬁcant evidence that TRPV4-containing channels have cri-
tical roles of controlling vascular tone [3,4,8,18,26,37,38,51,52].
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4.2. Heteromeric TRPV4-TRPC1 channels are not required for CaSR-
induced IKCa channel activation
Our previous work showed that in addition to NO generation, CaSR-
induced vasorelaxation is also mediated by activation of IKCa channels
in rabbit mesenteric artery ECs which presumably induces en-
dothelium-derived hyperpolarisations [24,25]. The present work shows
that [Ca2+]o-induced IKCa channel activation was not aﬀected by
RN1734 and T1E3 indicating that heteromeric TRPV4-TRPC1 channels
are unlikely to be involved. However, [Ca2+]o-induced IKCa channel
activation was abolished by the cation channel blocker, and pan-TRP
channel inhibitor, Gd3+[5]. This poses the intriguing possibility than
another TRP channel is coupled to CaSR stimulation, which mediates
Ca2+ inﬂux coupled to IKCa channel activation. A possible candidate is
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TRPC3, which is expressed in ECs and has been linked to EDH in several
diﬀerent vascular beds [23,31,45]. It is possible that CaSR-activated
TRP channels may be coupled to distinct functions via diﬀerent acti-
vation pathways. For example, receptor-operated TRP channels such as
TRPC3 may be coupled to IKCa channel activation and relaxation,
whereas store-operated TRPV4-TRPC1 channels may be coupled to NO
production and relaxation. What is clear is that there is need for future
detailed experiments on characterization of CaSR-evoked TRP channels
in ECs, their activation pathways, and their vascular function.
4.3. Are heteromeric TRPV4-TRPC1 channels the predominant native
TRPV4-containing channels in rabbit mesenteric artery ECs?
Our results show that the TRPV4 agonist GSK activated cation
channel activity with a unitary conductance of about 6pS in rabbit
mesenteric artery ECs, which was inhibited by RN1734 and T1E3.
These ﬁndings suggest that the predominant native TRPV4-containing
channels in these ECs are also composed of TRPC1 subunits forming a
heteromeric TRPV4-TRPC1 channel.
In contrast to the present work, over-expression of TRPV4 and
TRPC1 subunits and TRPV4-TRPC1 concatamers in HEK293 cells both
produced 4αPDD-evoked inward single channel activity which had a
unitary conductance of about 80pS [34,35], which is obviously very
diﬀerent from the 6pS conductance of the channels we recorded. It may
be that electrophysiological properties of these channels are diﬀerent in
over-expression systems compared to native cells in their physiological
environment. In addition, perhaps the low 6pS conductance also re-
ﬂects the presence of TRPP2, or other components, which form the
native channel. It will be important to investigate these diﬀerences in
the future.
Throughout this study the TRPC1 blocker T1E3 was not as eﬀective
in reducing CaSR-induced vasorelaxations, NO production, and GSK-
evoked cation channel activity compared to RN1734. The reason for
this is unclear, but it may be because the T1E3 blocking antibody is less
potent than a small molecular weight inhibitor. It is unlikely that dif-
ferences between the eﬀects of T1E3 and RN1734 are due to diﬀerent
populations of TRPV4-containing channels in our ECs, as we clearly
show that GSK only activated channels with a single 6pS conductance.
Sonkusare et al. [51] proposed that GSK-activated large amplitude
Ca2+ sparklets mediated by Ca2+ inﬂux through opening of a small
number TRPV4 channels (cooperative cluster of about 4 channels)
produce maximum endothelium-dependent vasorelaxation via stimu-
lation of SKCa and IKCa channels, but not NO production, in pressurised
3rd order mouse mesenteric arteries. In contrast, the present work
shows that GSK-induced vasorelaxation is mediated by NO generation
in 2nd order rabbit mesenteric arteries using wire myography. These
disparities may represent diﬀerences between species, pressurised ves-
sels and wire myography, and composition and cellular function of
TRPV4-containing channels in diﬀerent order vessels. It would be in-
teresting to investigate if the GSK-activated 6pS TRPV4-TRPC1 chan-
nels observed in rabbit mesenteric artery ECs could support suﬃcient
Ca2+ entry to mediate Ca2+ sparklets, and if TRPC1 is involved in GSK-
mediated Ca2+ sparklets and vasorelaxations in mouse mesenteric ar-
tery ECs. What is clear is that there is considerable evidence that TRPV4
has a signiﬁcant role in endothelium-dependent regulation of vascular
tone in physiological and pathological settings [3,15,37,43,51,52], and
that further work is needed to elucidate the role of TRPV4-containing
channels, including heteromeric TRPV4-TRPC1 structures, as potential
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therapeutic targets for vascular disease.
5. Conclusion
The major ﬁnding of this study is that activation of a native het-
eromeric 6pS TRPV4-TRPC1 channel is involved in CaSR-induced va-
sorelaxations through NO production in rabbit mesenteric artery ECs. In
addition, a distinct TRP-like cation channel is likely to be involved in
coupling CaSR stimulation to IKCa channel activation and vasorelaxa-
tion. These results further highlight the importance of CaSR and
TRPV4-TRPC1 channels in regulation of vascular tone, which may have
potential clinical implications, indicating that CaSR may represent
novel therapeutic targets for controlling vascular contractility.
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